Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies

ONCOLOGY

Volumn 12, Issue 1, 1998, Pages 99-106

  Fuchshuber, Pascal ^a   Loree, Thom R ^a   Delacure, Mark D ^a   Hicks Jr , Wesley L ^b  

^a Department of Head ^*

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROTROPIN;

ADULT; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; PROGNOSIS; RADIATION INJURY; REVIEW; THYROID CARCINOMA; THYROIDECTOMY; THYROIDITIS; TREATMENT FAILURE;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RISK ASSESSMENT; SURVIVAL RATE; THYROID DISEASES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0031883063     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA Cancel J Clin 46:5-27, 1996.
2. Jensen MH, Davis K, Derrick L: Thyroid cancer: A computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg 102:51-65, 1990.
3. Nikiforov Y, Gnepp DR, Fajin JM: Thyroid lesions in children and adolescent after the Chernobyl disaster: Implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81:9-14, 1996.
4. Cuello C, Correa P, Eisenberg H: Geographic pathology of thyroid carcinoma. Cancer 23:230-239, 1969.
5. Thompson NW: Endocrine neoplasia, in Niederhuber JE (ed): Current Therapy in Oncology, PP 240-248 St. Louis. Mosby Year Book-B.C. Decker, 1993
6. Shaha AR, Loree TL, Shah JP: Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138, 1995.
7. Lang W, Choritz H, Hundeshagen H: Risk factors in follicular thyroid carcinomas: A retrospective follow-up study covering a 14 year period with emphasis on morphological findings. Am J Surg Pathol 10:246-255, 1986.
8. DeGroot LJ, Kaplan EL, McCormick M. et al: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424, 1990.
9. Farid NR, Shi Y, Minjing Z: Molecular basis of thyroid cancer. Endocrine Rev 15:202-232, 1994.
10. Taruscio D, Carcangui ML, Ried T, et al: Numerical chromosome alterations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosomes Cancer 9:180-185, 1994.
11. Grieco M, Santoro M, Berlingieri MT, et al: PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinoma. Cell 60:557-563, 1990.
12. Bongarzone I, Butti MG. Coronelli S, et al: Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 54:2979-2985, 1994.
13. Hay ID, Grant CS, van Heerden JA, et al: Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 112:1139-1147, 1992.
14. Lin JD, Chao TC, Weng HF, et al: Clinical presentation and treatment of 74 occult thyroid carcinomas. Am J Clin Oncol 19:504-508, 1996.
15. Woeber KA: Cost-Effective evaluation of the patient with a thyroid nodule. Surg Clin North Am 75:357-363, 1995.
16. Saunders LE, Rossi RL: Occult well differentiated carcinoma presenting as cervical node disease. World J Surg 19:642-647, 1995
17. Reverter RL, Lucas A, Salinas I, et al: Suppressive therapy with levothyroxine for solitary nodules Clin Endocrinol 36:25-29, 1992.
18. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953, 1988.
19. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095, 1987.
20. Hay ID, Bergstrath EJ, Goellner JR, et al: Predicting outcome in papillary carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058, 1993.
21. Shah, JP, Loree TL, Dharker D, et al: Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surgery 164:658-661, 1992.
22. Shaha AR, Loree TL, Shah JP: Intermediate-risk group for differentiated carcinoma of the thyroid. Surgery 116:1036-1041, 1994.
23. Shaha AR, Loree TL, Shah JP: Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138, 1995.
24. Terry JH, St. John SA, Karkowski FJ et al: Tall cell papillary thyroid cancer: Incidence and prognosis. Am 7 Surg 168:459-461, 1994
25. Russel MA, Gilbert EF, Jaeschke WR. Prognostic features of thyroid cancer. Cancer 36:553-559, 1975.
26. Tollefsen HR, Shah JP, Huvos AG: Papillary carcinoma of the thyroid: Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 124:468-472, 1972.
27. McConahey WM, Hay ID, Woolner LB, et al: Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970: Initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:968-975, 1986.
28. Rossi RL, Cady B, Silverman ML, et al: Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 10:612-622, 1986.
29. Coburn MC, Wanebo HJ: Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 164:671-676, 1992.
30. Hay ID: Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576, 1994.
31. Cunningham MP, Duda RB, Recant W, et al: Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344-347, 1990.
32. Hirabayashi RN, Lindsay S: Carcinoma of the thyroid gland: A statistical study of 390 patients. J Clin Endocrinol Metab 21-1596-1610, 1961.
33. Cady B, Sedwick CE, Meissner WA, et al: Changing clinical, pathological, therapeutic, and survival patterns in differentiated thyroid cancer. Ann Surg 18:541-553, 1976.
34. Rossi RL, Nieroda C, Cady B, Wool MS: Malignancies of the thyroid gland: The Lahey Clinic experience. Surg Clin North Am 65:211-230, 1985.
35. Hughes CJ, Shaha AR, Shah JP, et al: Impact of lymph node metastases in differentiated carcinoma of the thyroid: a matched pair analysis. Head & Neck 18:127-132, 1996.
36. Harwood J, Clark OH, Dunphy JE: Significance of lymph node metastasis in differentiated thyroid cancer Am J Surg 136:107-112, 1978.
37. Sellers M, Beenken S, Blankenship A: Prognostic significance of cervical lymph node metastasis in differentiated thyroid cancer. Am J Surg 164:578-581, 1992.
38. Mazzaferri E, Young RL: Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511-518, 1981.
39. Shah JP, Loree TR, Dharker D, et al: Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched pair analysis. Am J Surg 166:331-335, 1993.
40. Clark OH, Levin K, Zeng Q, et al: Thyroid cancer: The case for total thyroidectomy. Eur J Clin Oncol 24:305-313, 1988.
41. Beierwaltes WH, Rabbani R, Dmuchowski C, et al: An analysis of "ablation of thyroid remnants" with 1131 in 511 patients from 1947-1984; Experience at University of Michigan. J Nucl Med 25:1287-1293, 1984.
42. Varma VM, Beierwaltes WH, Nofal MM, et al: Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131. JAMA 214:1437-1442, 1970.
43. Hay ID, Grebe SK: Relative value of medical treatment with radioactive iodine and thyroid suppression as adjuvants after primary surgery for differentiated follicular-cell derived thyroid carcinoma. Proc 4th Int Conf Head Neck Cancer, pp 988-994, 1996.
44. Cohn KH, Backdahl M, Forsslund G, et al: Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96:957-970, 1984.
45. Schroder DM, Chambers A, France CJ: Operative strategy for thyroid cancer: Is total thyroidectomy worth the price? Cancer 58:2320-2328, 1986.
46. Loree TR: Therapeutic implications of prognostic factors in differentiated carcinoma of the thyroid gland. Semin Surg Oncol 11:246-255,1995.
47. Harness JK, Fung L, Thompson MN, et al: Total thyroidectomy: Complications and technique. World J Surg 10:781-786, 1986.
48. Flynn MB, Lyons KJ, Tarter JW, et al: Local complications after surgical resection for thyroid carcinoma. Am J Surg 168:404-407, 1994.
49. Van Heerden JA, Groh MA, Grant GS: Early postoperative morbidity after surgical treatment of thy roid carcinoma. Surgery 101:224-227, 1987.
50. Goepfert H, Callender DL: Differentiated thyroid cancer: Papillary and follicular carcinomas. Am J Otol 15:164-179, 1994.
51. Scheumann GFW, Grimm O, Wegener G, et al: Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559-568, 1994.
52. McGregor GI, Luoma A, Jackson SM: Lymph node metastases from well differentiated thyroid cancer: A clinical review. Am J Surg 149:610-612, 1985.
53. Mazzaferri EL: Papillary thyroid carcinoma: Factors influencing prognosis and current therapy. Semin Oncol 14:315-332, 1987.
54. Joensuu H, Klemi PJ, Paul R, et al: Survival and prognostic factors in thyroid carcinoma. Acta Radiol Oncol 25:243-248, 1986.
55. Maxon HR, Smith HS: Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685-718, 1990.
56. Samaan NA, Schultz PN, Mickey RC, et al. The results of various modalities of treatment of well-differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720, 1992.
57. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 95:418-428, 1994.
58. DeGroot LJ, Kaplan EL, Shukla MS, et al: Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80:2946-2953, 1995.
59. Hay ID: Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576, 1990.
60. Young RL, Mazzaferri EL, Rahe SM, et al: Pure follicular thyroid carcinoma: Impact of therapy in 214 patients. J Nucl Med 21:733-738, 1980.
61. Tubiana M, Schlumberger M, Rougicr P, et al: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794 804, 1985.
62. Snyder J, Gorman C, Scanlon P: Thyroid remnant ablation: Questionable pursuit of an ill-defined goal. J Nucl Med 24:659-665, 1983.
63. Edmonds CJ, Smith T: The long-term hazards of the treatment of thyroid cancer with radioiodine. Rr J Radiol 59:45-51, 1986.
64. Szanto J, Ringwald G, Karika Z, et al: Follicular cancer of the thyroid gland. Oncology 48:483-489, 1991.
65. Ruegemer J, Hay ID, Bergstrahl EJ, el al: Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508, 1988.
66. Mazzaferri EL, Young RL, Oertel JE, et al: Papillary thyroid carcinomas: The impact of therapy in 576 patients. Medicine 56:171-196, 1977.
67. Roti E, Minelli R, Gardini E, et al: The use and misuse of thyroid hormone. Endocrinol Rev 14:401-418, 1993.
68. Kobayashi T, Asakawa H, Yasuhiro T, et al: Fatal differentiated thyroid cancer. J Surg Oncol 62:123-127, 1996.
69. Brown AP, Greening WP, McCready VR, et al: Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience. Br J Radiol 57:323-327, 1984.
70. Har-El G: Locally aggressive differentiated thyroid cancer. Proc 4th Int Conf Head Neck, pp 972-987, 1996.
71. Powell S, Harmer C: Thyroid cancer causing death after 40 years: Rationale for initial intensive treatment. Eur J Surg Oncol 16:457-461, 1990.
72. Ross DS: Long-term management of differentiated thyroid cancer. Endocrinol Clin North Am 19:719-739, 1990.
73. Ozaka M, Suzuki S, Miyamoto T, Lui TR, et al: Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105, 1994.
74. Van de Velde CJH, Hamming JF, Goslings BM, et al: Report of the consensus development conference on the management of differentiated thyroid cancer in the Nederlands. Eur J Cancer Clin Oncol 24:287-292, 1988.